Ailsa Craig and Marek Poszepczynski, portfolio managers at the International Biotechnology Trust, tell MoneyWeek where they’d ...

China is now setting the pace in life sciences R&D, conducting more clinical trials than the U.S. and licensing new ...

The company will engage in BIO One-on-One Partnering™ meetings as it advances Phase 1 for Ketamir-2, prepares Phase IIa study ...

Job cuts at home-grown pharma companies like Arvinas and RallyBio and federal policies challenge CT biotech 'ecosystem' that ...

A new era of medical science is taking shape in Massachusetts. Our biotech companies are at work on a gene therapy that can cure deafness, treatments that slow the effects of aging, and a ...

The Phase 1/2 clinical trial ( NCT06810544) is evaluating the safety, pharmacokinetics, pharmacodynamics and antitumor activity of TNG456 as a monotherapy and in combination with abemaciclib. We are ...

The deal “fits like a glove” for BioMarin’s business, according to an analyst who also thinks there could be a “valuable” ...

A Cambridge-based pharmaceutical company is laying off close to a hundred ... Beth Treffeisen is a general assignment reporter for Boston.com, focusing on local news, crime, and business in ...

An international pharmaceutical research company will lay off 83 Boston-area employees by the end of June, according to new filings with the state. Ono Pharma, the United States subsidiary of a ...

“Lots of companies are limping along,” said Mani Foroohar, senior research analyst at Boston health care investment bank Leerink Partners. Foroohar, a top biotech analyst, has slapped an ...

In late 2021, bioengineer Jason Kelly became a billionaire for, as he put it, “a hot minute”. Investors in Ginkgo Bioworks Holdings, the Boston company he co-founded, had driven its market ...